Because disease outcomes and responses to treatment can vary across populations, clinical research must include patients who are racially, ethnically and gender representative of those who experience health conditions.
Scientists are pioneering new ways of achieving inclusive and diverse clinical trials, which can lead to a better understanding of disease biology and ultimately improved treatment and care for women and other populations that have historically been excluded from research in the past.
Tune in to hear Maria Wilson, Executive Director, Project Team Leader, Genentech sits down with Nicole Richie, Global Head of Health Equity and Population Science, and Jenn Pangilinan, Vice President, Genentech Research and Early Development (gRED) Clinical Operations, discuss the nuances of human biological difference and how we can take a more thoughtful approach to diversity in clinical trials.